KR940004076B1 - 핵산 유도체의 제조방법 - Google Patents

핵산 유도체의 제조방법 Download PDF

Info

Publication number
KR940004076B1
KR940004076B1 KR1019870000061A KR870000061A KR940004076B1 KR 940004076 B1 KR940004076 B1 KR 940004076B1 KR 1019870000061 A KR1019870000061 A KR 1019870000061A KR 870000061 A KR870000061 A KR 870000061A KR 940004076 B1 KR940004076 B1 KR 940004076B1
Authority
KR
South Korea
Prior art keywords
nucleic acid
poly
present
test sample
acid derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1019870000061A
Other languages
English (en)
Korean (ko)
Other versions
KR870007198A (ko
Inventor
쥰이찌 야노
다다아끼 오오끼
Original Assignee
닛본신야꾸 가부시기가이샤
모리시따 히로시
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 닛본신야꾸 가부시기가이샤, 모리시따 히로시 filed Critical 닛본신야꾸 가부시기가이샤
Publication of KR870007198A publication Critical patent/KR870007198A/ko
Application granted granted Critical
Publication of KR940004076B1 publication Critical patent/KR940004076B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
KR1019870000061A 1986-01-06 1987-01-06 핵산 유도체의 제조방법 Expired - Lifetime KR940004076B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP61-001076 1986-01-06
JP1076 1986-01-06
JP107686 1986-01-06

Publications (2)

Publication Number Publication Date
KR870007198A KR870007198A (ko) 1987-08-17
KR940004076B1 true KR940004076B1 (ko) 1994-05-11

Family

ID=11491410

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019870000061A Expired - Lifetime KR940004076B1 (ko) 1986-01-06 1987-01-06 핵산 유도체의 제조방법

Country Status (11)

Country Link
JP (1) JPS62252798A (enrdf_load_html_response)
KR (1) KR940004076B1 (enrdf_load_html_response)
BE (1) BE906157A (enrdf_load_html_response)
CA (1) CA1315717C (enrdf_load_html_response)
CH (1) CH671960A5 (enrdf_load_html_response)
DE (1) DE3700164A1 (enrdf_load_html_response)
ES (1) ES2004038A6 (enrdf_load_html_response)
FR (1) FR2596762B1 (enrdf_load_html_response)
GB (1) GB2185026B (enrdf_load_html_response)
NL (1) NL8700016A (enrdf_load_html_response)
SE (1) SE469594B (enrdf_load_html_response)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2222334C2 (ru) 1998-05-25 2004-01-27 Ниппон Синяку Ко., Лтд. Способ получения композитного препарата, содержащего нуклеиновую кислоту
CA2459373A1 (en) * 2001-09-04 2003-03-20 Nippon Shinyaku Co., Ltd. Method of evaluating efficacy of nucleic acid therapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB906851A (en) * 1960-05-03 1962-09-26 Schwarz Bio Res Inc Thiolation of polymers
DE2041735A1 (de) * 1970-08-22 1972-02-24 Merck Patent Gmbh Thio-pyrimidin-derivate
GB1364987A (en) * 1971-06-19 1974-08-29 Merck Patent Gmbh Biologically active two component complexes
GB2038628A (en) * 1978-11-14 1980-07-30 Searle & Co Physiological compositions comprising poly(4-thiouridylic acid) or copolymers thereof and the use thereof as anti-viral agents or serum cholesterol lowering agents

Also Published As

Publication number Publication date
DE3700164A1 (de) 1987-07-09
JPS62252798A (ja) 1987-11-04
CH671960A5 (enrdf_load_html_response) 1989-10-13
BE906157A (fr) 1987-07-01
GB2185026B (en) 1990-08-08
CA1315717C (en) 1993-04-06
FR2596762B1 (fr) 1993-10-08
GB8700183D0 (en) 1987-02-11
KR870007198A (ko) 1987-08-17
DE3700164C2 (enrdf_load_html_response) 1993-02-25
ES2004038A6 (es) 1988-12-01
SE8605616L (sv) 1987-07-07
FR2596762A1 (fr) 1987-10-09
GB2185026A (en) 1987-07-08
SE469594B (sv) 1993-08-02
SE8605616D0 (sv) 1986-12-30
NL8700016A (nl) 1987-08-03

Similar Documents

Publication Publication Date Title
US20200289662A1 (en) Antibody-active agent conjugates and methods of use
CA3076712C (en) Antibody-drug conjugates and uses thereof
AU2017213503B2 (en) Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
KR960009054B1 (ko) 사람 유래의 당단백질 및 그 당단백질로서 되는 생리활성인자와 이를 활성 성분으로 하는 제제
EP0335423B1 (en) Modified human G-CSF
US4880784A (en) Antiviral methods utilizing ribofuranosylthiazolo[4,5-d]pyrimdine derivatives
EP0636372B1 (en) Antiviral, antitumor, antimetastatic, immune system enhancing 7-thia-guanosine derivatives
EP3523314A1 (de) Benzimidazolhaltige cyclische dinukleotide, verfahren zu deren herstellung und ihre verwendung zur aktivierung von stimulator von interferongenen (sting)-abhängigen signalwegen
MX2014007483A (es) Polipeptidos de receptores de activina variantes y sus usos.
EP2934596A1 (en) Linker-payload molecule conjugates
DE69823501T2 (de) Verwendung von wolinella succinogenes asparaginase zur behandlung von asparagin-abhängiger krankheiten
EP4534090A1 (en) Oligosaccharide linker, linker-supported material comprising oligosaccharide linker, antibody-drug conjugate having sugar chain remodeling, preparation method therefor and use thereof
CA1334174C (en) 2- and 8-azido (2'-5')oligoadenylates and antiviral uses thereof
Multani et al. Reduction of telomeric signals in murine melanoma and human breast cancer cell lines treated with 3'-azido-2'-3'-dideoxythymidine.
KR940004076B1 (ko) 핵산 유도체의 제조방법
CN119061009A (zh) 一种新型的双链siRNA、其缀合物及其用途
Akimoto et al. Queuine analogs. Their synthesis and inhibition of growth of mouse L5178Y cells in vitro
KR20010029544A (ko) 천연형 항종양성 또는 항바이러스성 물질 및 이의 용도
Zheng et al. Synthesis of Myristoyl CoA Analogues and Myristoyl Peptides as Inhibitors of Myristoyl CoA: Protein/V-Myristoyltransferase
EP0320807A2 (en) Novel polynucleotide analogs, methods for inhibiting nucleic acid polymerases and methods for inducing synthesis of interferon
KR20160029817A (ko) 황산화 폴리굴론산 폴리사카라이드 또는 그의 제약 염, 그의 제조 방법 및 그의 용도
RU2809355C1 (ru) РЕКОМБИНАНТНАЯ ПЛАЗМИДА pET32a-TNF-Thy, ОБЕСПЕЧИВАЮЩАЯ СИНТЕЗ ГИБРИДНОГО БЕЛКА α-ФАКТОР НЕКРОЗА ОПУХОЛЕЙ - ТИМОЗИН АЛЬФА 1, ШТАММ БАКТЕРИЙ ESCHERICHIA COLI BL21 (DE3)/pET32A-TNF-Thy - ПРОДУЦЕНТ ГИБРИДНОГО БЕЛКА TNF-Thy, СПОСОБ ПОЛУЧЕНИЯ ГИБРИДНОГО БЕЛКА TNF-Thy И ЛЕКАРСТВЕННОЕ СРЕДСТВО
US20250042936A1 (en) Method for glycosylation modification of proteins and/or polypeptides
HK40049376A (en) Rna inhibitor for inhibiting hepatitis b virus gene expression and application thereof
HK40049376B (en) Rna inhibitor for inhibiting hepatitis b virus gene expression and application thereof

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19870106

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19910916

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19870106

Comment text: Patent Application

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

Comment text: Decision on Publication of Application

Patent event code: PG16051S01I

Patent event date: 19940418

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19940723

NORF Unpaid initial registration fee
PC1904 Unpaid initial registration fee